Understanding conventional and novel risk factors, including structural remodeling and fibrosis, may help delay AF progression and reduce arrhythmia burden.
No takes yet. Share an insight, caveat, or question.
May aid AF risk stratification; leaves open prospective validation of fibrotic markers for progression.
Vlachos et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: